Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.

Abstract

OBJECTIVE There have been no endpoint studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular endpoints and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine… (More)

Topics

Cite this paper

@article{Stegmayr2005LowdoseAI, title={Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study.}, author={B. G. Stegmayr and Monica Br{\"a}nnstr{\"{o}m and Sara Bucht and V Crougneau and Em{\"{o}ke M Dim{\'e}ny and Anders Ekspong and Mats Eriksson and Barbara Granroth and K C Gr{\"{o}ntoft and Henrik Hadimeri and Bj{\"{o}rn Holmberg and Bo Ingman and Bengt Isaksson and Gunnar Johansson and Kerstin Lindberger and L A Carina Lundberg and Laila Mikaelsson and E. -H. Olausson and Bengt Persson and Hans Stenlund and Ann Marie Wikdahl}, journal={Scandinavian journal of urology and nephrology}, year={2005}, volume={39 6}, pages={489-97} }